Paul Hastings LLP’s full-service patent litigation practice is reputed for its technical expertise and success in representing notable clients in the life sciences and technology sectors, including Meta, Google, Samsung and BioNTech. The team often works on precedent-setting matters, such as their recent victory for Allergan which will transform Obviousness-type Double Patenting (ODP) in the pharmaceutical industry. The practice also showcases expertise in high-value trade secret matters. Chairing the practice are three IP specialists: Naveen Modi, located in Washington DC, is an expert in post-grant patent and appellate proceedings, particularly before the USPTO and Court of Appeals; New York’s Bruce Wexler, who focuses on life sciences patent litigation and represents large and start-up biotech companies; and Eric Dittmann, who is also based in New York and is seasoned in trying business-critical patent cases, with a core focus on biotech and Hatch-Waxman cases. Another key contact in New York is Melanie Rupert whose experiences extend to the biotech, pharmaceutical and medical device industries. Lisa Nguyen, along with five fellow partners, joined the team in March 2024 from A&O Shearman.
L’éditorial du Legal 500

Clients clés

  • Meta Platforms
  • Google LLC
  • Samsung Electronics
  • AbbVie
  • BioNTech
  • Stanley Black and Decker
  • Viking Therapeutics
  • Daiichi Sankyo
  • Medtronic Inc.
  • L’Oreal

Points forts

  • Triumphed on behalf of Allergan as the Federal Circuit fully revived claims of patents covering Allergan's bowel treatment drug Viberzi, effectively transforming the doctrine of Obviousness-type Double Patenting (“ODP”) in a closely watched decision impacting virtually every major pharmaceutical product in the market. The ODP issue will impact hundreds of billions (if not trillions) in pharmaceutical product sales.
  • Successfully defended Google against Flypsi over patents concerning Voice over IP technology, first in a hard-fought six-day jury trial where Flypsi’s damages were limited to $12 million dollars as a lump sum covering the entire life of the asserted patents. A coordinated strategy between the district court and the PTAB led to the PTAB finding every challenged claim of every challenged patent (including every asserted claim) invalid.
  • Obtained a complete victory in an arbitration on behalf of Daiichi Sankyo, a global pharmaceutical company and the largest in Japan by market cap, in a hotly contested, complex commercial dispute with Seagen, Inc., which sought to extract tens of billions of dollars, plus worldwide ownership of Daiichi Sankyo’s proprietary portfolio of pioneering drugs for treating patients suffering from deadly cancers, plus global patent rights to more than 350 Daiichi Sankyo patents and patent applications, from our client.

Avocats

Les grands avocats du marché

Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.

Naveen Modi

Responsable de la pratique

Naveen Modi; Bruce Wexler; Eric Dittmann

Autres avocats clés

Melanie Rupert; Lisa Nguyen